CYTOSORBENTS CORPORATION - COMMON STOCK
0.9400
02-May-25 16:45:00
15 minutes delayed
Stocks
-0.0700
-6.93%
Today's range
0.8700 - 0.9439
ISIN
N/A
Source
NASDAQ
-
04 Mar 2025 07:00:00 By Nasdaq GlobeNewswire
-
26 Feb 2025 07:00:00 By Nasdaq GlobeNewswire
-
25 Feb 2025 07:00:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months High: CYTOSORBENTS CORPORATION - COMMON STOCK
14 Feb 2025 15:29:08 By NetDania Notify
-
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
13 Jan 2025 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai
06 Jan 2025 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue
03 Jan 2025 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Rights Offering Begins
23 Dec 2024 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Announces Rights Offering
09 Dec 2024 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference
26 Nov 2024 07:00:00 By Nasdaq GlobeNewswire
-
11 Nov 2024 07:30:00 By Nasdaq GlobeNewswire
-
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
07 Nov 2024 16:05:02 By Nasdaq GlobeNewswire
-
04 Nov 2024 07:00:00 By Nasdaq GlobeNewswire
-
22 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents to Report Third Quarter 2024 Operating and Financial Results
17 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
27 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16 Aug 2024 16:05:00 By Nasdaq GlobeNewswire
-
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
13 Aug 2024 16:19:55 By Nasdaq GlobeNewswire
-
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
13 Aug 2024 16:18:28 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >